skip to primary navigationskip to content

Cambridge Service Alliance

developing new understanding and approaches to complex service systems

Studying at Cambridge

 

Ecosystems Evolution Enabled by Technology

Ecosystem evolution enabled by technology – an example in Healthcare

Healthcare is changing – fast

The search for new business models for the Pharmaceutical industry is being driven by a number of factors:

  1. Society’s healthcare burden is growing due to populations that are living longer (and being unwell for longer)
  2. Payors want to now pay for outcomes from medicines not just for the pills
  3. Generics (launched after patent expiry) are cutting the value of established brands and markets
  4. Pharma R&D is not producing the blockbusters companies have needed to support their revenues
  5. Pharmaceutical companies are looking to switch roles from being pure manufacturers to service providers delivering outcomes

 

Is personalised medicine finally here?

IBM’s Smarter Planet concept – that increasing instrumentation and interconnections are making the world more intelligent – shows that by connecting healthcare devices such as pill dispensers, and health monitoring devices (e.g. glucose meters, etc), insight can be gained to health at the individual, and population scale.

Such insight would benefit multiple stakeholders in the healthcare ecosystem:

Patients quantify their health outcomes, and Carers receive support through reminders. 
Healthcare providers gain insight to patient health, from which to recommend appropriate interventions.  Payors benefit from lower healthcare costs and focus on patient outcomes

New players are going to change the health ecosystem

The large-scale, long-term deployment of this approach, based on an extensive collaboration between healthcare and technology could deliver:

  1. Novel analytical techniques enabling patients, HCPs, and other stakeholders to act quickly 
  2. Accelerated incorporation of analytics using advanced, predictive capabilities for pattern and context recognition into health assessment
  3. Value-based pricing for medicines based on pseudo real-time health outcomes data that will radically alter the way in which medicines are developed and priced by the pharmaceutical industry.

Contact: Amer Fasihi

Filed under: , ,

RSS Feed Latest news

New thinking about the future of services

Apr 14, 2019

New thinking about the future of services - Connecting the digital, physical and social

2018 Robert Johnston Award

Apr 03, 2019

Congratulations to Mohamed Zaki, Professor Janet McColl-Kennedy and co-authors for receiving the 2018 Robert Johnston Award of the Journal of Service Management

Webinar on High-Value Manufacuring (HVM)

Mar 18, 2019

In this webinar, Luisa Huaccho Huatuco presents the Alliance February 2019 paper on High-Value Manufacturing.

February 2019 Paper - High Value Manufacturing (HVM) in the UK: Case studies and focus group insights

Feb 28, 2019

High Value Manufacturing (HVM) in the UK: Case studies and focus group insights by Luisa Huaccho Huatuco, Veronica Martinez-Hernandez, Thomas F. Burgess and Nicky E. Shaw

February 2019 Webinar - Business Ecosystems Mapping

Feb 12, 2019

In this webinar, Florian presents the Alliance January 2019 paper on Business Ecosystems Mapping.

View all news

Upcoming events

Shift to Services Executive Education Programme

May 14, 2019

IfM, Cambridge, UK

Upcoming events